Hematologic
Skyhawk Therapeutics to Present Preclinical Data of SKY-1214 Combination Treatment in Hematologic Cancers
Skyhawk
PR-11-24-NI-118Nov 21, 2024
Clinical Data
Skyhawk Therapeutics Presents Compelling Preclinical Data at the Molecular Targets and Cancer Therapeutics Symposium
Skyhawk
PR-10-24-NI-62Oct 25, 2024
RNA Splicing
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
Biogen
PR-M01-19-NI-032Jan 11, 2019
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform
Skyhawk
PA4048Jun 28, 2018